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Human immunodeficiency virus (HIV) delivers its genome to a host cell through fusion of the viral envelope with a cellular membrane. While
the viral and cellular proteins involved in entry have been analyzed in detail, the dynamics of virus–cell fusion are largely unknown. Single virus
tracing (SVT) provides the unique opportunity to visualize viral particles in real time allowing direct observation of the dynamics of this stochastic
process. For this purpose, we developed a double-coloured HIV derivative carrying a green fluorescent label attached to the viral matrix protein
combined with a red label fused to the viral Vpr protein designed to distinguish between complete virions and subviral particles lacking MA after
membrane fusion. We present here a detailed characterization of this novel tool together with exemplary live cell imaging studies, demonstrating
its suitability for real-time analyses of HIV–cell interaction.
© 2006 Elsevier Inc. All rights reserved.Keywords: HIV-1; Single virus tracing; Virus entry; Fluorescence labelling; Heparan sulfateIntroduction
Entry of enveloped viruses and delivery of their genome into
a susceptible cell starts by fusion of the viral lipid envelope with
a cellular membrane. Fusion can take place either at the plasma
membrane or at intracellular membranes, most notably those of
the endosomal pathway, and both strategies are used by
different viruses (for review, see Eckert and Kim, 2001;
Sieczkarski and Whittaker, 2005). While the cellular attachment
molecules, receptors and coreceptors, and the viral surface
molecules mediating entry are known for many viruses and
have been analyzed in detail, there is currently little information
available concerning the dynamics of viral entry. This is mainly
due to the fact that bulk biochemical models can yield only
limited information on the kinetics of this stochastic process and
suitable methods for tracking individual virus entry events with
high temporal and spatial resolution have been lacking.⁎ Corresponding author. Fax: +49 6221 565003.
E-mail address: Barbara_Mueller@med.uni-heidelberg.de (B. Müller).
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doi:10.1016/j.virol.2006.10.005Recently, biophysical imaging techniques allowing observa-
tion of individual fluorescently labelled molecules or particles
in living cells have become available. Such methods are ideally
suited for the analysis of dynamic events involved in virus–cell
interactions. They have been applied to investigate the entry
processes of the non-enveloped viruses adeno-associated virus
(AAV; Seisenberger et al., 2001), adenovirus (Suomalainen et
al., 1999), SV40 (Damm et al., 2005) and polyomavirus (Ewers
et al., 2005), as well as of the enveloped viruses influenza virus
(Lakadamyali et al., 2003; Rust et al., 2004), rabies virus (Finke
et al., 2004) and murine leukemia virus (Lehmann et al., 2005).
Having previously established a method for single virus tracing
(SVT) based on wide-field imaging, which allows direct
observation of fluorescently labelled AAV virions in real time
with single molecule sensitivity (Seisenberger et al., 2001;
Bräuchle et al., 2002), we wanted to adapt this technique to
study the entry process of human immunodeficiency virus type 1
(HIV-1).
Previous studies on HIV fusion dynamics have mainly
employed bulk measurements using cell–cell fusion assays (see
Gallo et al., 2003, for review) and indirect readout methods to
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entry events were synchronized through pre-binding and
temperature shift (Raviv et al., 2002; Markosyan et al., 2005).
In contrast, SVT using fluorescently labelled virus derivatives
allows direct analysis of fast steps in the interaction of
individual particles with host cells in tissue culture at 37 °C.
A prerequisite for the application of this technique is the
introduction of an appropriate fluorescent label into the virion.
In the case of HIV, a labelling strategy which allows
discrimination between complete particles and subviral com-
plexes would be highly advantageous. It has long been
established that productive HIV entry can occur by direct
fusion at the plasma membrane, mediated by interaction of the
viral surface glycoprotein with the cellular receptor CD4 and
co-receptor molecules, but productive entry of HIV particles
through an endocytic pathway and pH-independent fusion has
also been observed (Daecke et al., 2005). In analyses of
individual cell entry events by SVT it is thus crucial to
discriminate between fusion at the plasma membrane and
uptake of complete particles by endocytosis. Towards this end,
we have combined our previously described HIV-1 derivative,
which carries an enhanced GFP (eGFP) domain attached to the
membrane bound matrix (MA) region of the HIV structural
protein Gag (Müller et al., 2004), with an mRFP1-labelled Vpr
derivative. Fluorescent labelling of the virion incorporated
protein Vpr has been used previously to follow the intracellular
trafficking of viral pre-integration complexes after fusion
(McDonald et al., 2002). The novel dual-labelling strategy
described here should allow distinguishing intact double-
coloured viruses from single-coloured subviral particles result-
ing from membrane fusion. As an essential prerequisite for the
suitability of double-labelled HIV for studies on virus–cell
interaction, we have carried out a detailed analysis on the
functionality and fluorescence characteristics of the labelled
HIV particles under conditions suitable for live cell imaging.
Results and discussion
Characterization of double-labelled infectious HIV-1 particles
We had previously generated an infectious fluorescently
labelled HIV-1 derivative carrying eGFP attached to the
membrane bound MA domain of the main HIV-1 structural
protein Gag as a tool for studying the dynamics of HIV–cell
interaction. Cells transfected with this plasmid released
fluorescently labelled particles. Mixed particles generated by
co-transfection with an equimolar amount of wild-type genomes
retained full infectivity while carrying an average of approxi-
mately 2500 molecules of eGFP (Müller et al., 2004). Initial
microscopic studies aimed at investigating the interaction of
fluorescently labelled particles with cells revealed very efficient
binding of these particles to CD4-positive HeLaP4 cells (data
not shown). It remained unclear, however, whether bound
particles subsequently underwent fusion or remained as
complete particles at the membrane. Accordingly, single
labelled particles did not appear suitable for the study of HIV-
1 entry kinetics. We therefore decided to establish a double-labelling strategy in which the fluorescent label at the viral MA
protein was combined with a differently coloured fluorescent
protein fused to the viral protein Vpr. Exogenously expressed
Vpr.eGFP had previously been shown to be incorporated into
viral particles and was used to follow trafficking of viral
replication complexes after cell entry (McDonald et al., 2002).
Vpr is believed to largely remain with the viral replication and
pre-integration complexes after fusion. In contrast, the vast
majority of the membrane-attached MA molecules is expected
to separate from the core immediately after membrane removal.
Using double-labelling of HIV-1 particles in MA and Vpr, we
should thus be able to distinguish extra- and intracellular
double-labelled complete particles from single-labelled subviral
complexes that have lost the MA layer. Initial investigations
established that a combination of eGFP and monomeric red
fluorescent protein (mRFP1) displayed better spectral separa-
tion and less photobleaching than the combination of cyan and
yellow fluorescent proteins (data not shown). Hence, a
combination of MA.eGFP and mRFP.Vpr was used in all
subsequent experiments involving fluorescently double-
labelled virions.
Our first aim was to determine whether such double-labelled
HIV-1 particles could be generated efficiently and whether they
retained infectivity. Previously, we observed that particles
containing an equimolar mixture of native and eGFP-labelled
Gag exhibited wild-type infectivity, while particles made only
from Gag.eGFP were significantly less infectious (Müller et al.,
2004). We therefore produced double-labelled particles by
transfection of 293T cells with a 1:1 mixture of HIV-1 proviral
DNA and its eGFP-tagged derivative together with a plasmid
encoding the mRFP.Vpr fusion protein. Wild-type HIV-1, as
well as single-labelled particles carrying only one of the two
fluorescent fusion proteins, were generated in parallel.
To analyze whether viruses containing the modified proteins
displayed normal protein composition and Gag processing,
particles were centrifuged through a sucrose cushion and their
protein composition was analyzed by immunoblotting using
antisera against different HIV-1 proteins (Fig. 1A). Staining
with antiserum against MA revealed that the MA.eGFP-labelled
particles (lanes 2 and 3) contained comparable amounts of wild-
type and eGFP-tagged Gag and MA. The fusion proteins were
also detected using an antibody against eGFP (data not shown).
In the presence of exogenously expressed mRFP.Vpr (lanes 3
and 4) Gag processing appeared to be impaired (compare lanes
1 and 4, as well as 2 and 3, respectively; see also below).
Immunoblotting using αgp120 showed that comparable
amounts of Env were incorporated in all cases. Antiserum
against Vpr revealed virion incorporation of the mRFP.Vpr
fusion protein with an apparent molecular mass of 38 kDa as
well as wild-type Vpr produced from the proviral plasmids
(migrating at 14 kDa). A smaller amount of an anti-Vpr reactive
protein of approximately 30 kDa was also detected, presumably
representing a product of internal proteolysis within mRFP1.
The exogenously expressed mRFP.Vpr gave a much stronger
band than the native Vpr indicating that over-expression of the
fusion protein leads to increased virion incorporation. We had
previously determined Vpr in wild-type HIVNL4-3 to be present
Fig. 2. Relative infectivity of fluorescently labelled VLPs. Particles obtained by
co-transfection of 293T cells with the indicated plasmids were quantitated by
p24 ELISA and titrated in triplicate on TZM reporter cells. At 48 hpi, infected
cells were quantitated by luminescence measurements as described in Materials
and methods and relative light units (RLU) per ng p24 were calculated. The
figure shows data from one representative experiment. Two additional
independent titrations yielded similar data.
Fig. 1. Characterization of double-labelled virions. (A) Virus particles were prepared from the tissue culture supernatant of 293Tcells transfected with proviral plasmid
pNLC4-3 (lane 1), pNLC4-3 and pNLC4-3.eGFP (lane 2), pNLC4-3, pNLC4-3.eGFP and pmRFP.Vpr (lane 3) or pNLC4-3 and pmRFP.Vpr (lane 4), respectively.
Following particle concentration through a sucrose cushion, viral proteins were separated by SDS–PAGE and detected by immunoblotting using polyclonal antisera
raised against HIV-1 MA, Vpr or gp120 respectively. Positions of molecular weight standards in kDa are indicated to the left. The minor differences in gp120
incorporation were not reproducible when performing immunoblots using particle preparations from three independent experiments. (B) Virions prepared as in panel A
were visualized by fluorescence microscopy using the experimental setup described in Materials and methods.
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which corresponds to approximately 700 molecules, based on
an average of 4900 molecules of Gag per particle (Briggs et al.,
2004). Thus, over-expression of mRFP.Vpr led to the
incorporation of far more than 1000 molecules of labelled
Vpr per particle. Imaging of particles produced by this triple co-
transfection showed that the vast majority of signals was dual-
coloured confirming that both labels were contained within the
same particles (Fig. 1B; see also below).
Relative infectivities of single- and double-labelled viruses
were determined by titration of tissue culture supernatants from
co-transfected cells on TZM reporter cells, which express
luciferase under the control of the HIV-1 LTR (Wei et al., 2002).
Infection leads to Tat-stimulated luciferase expression, which
can be quantitated by a luminometric assay. The results from
one such experiment are shown in Fig. 2. Infectivity was mildly
reduced in the case of single labelling of either MA or Vpr,
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effect. In this case, the luminescence signal per input antigen (as
determined by p24 ELISA) was reduced approximately fivefold
compared to wild-type HIV-1. This effect is most likely due to
the reduced Gag polyprotein processing in the presence of both
fluorophores (Fig. 1A), and may result from molecular
crowding in virus particles carrying a large number of
fluorescent protein domains in addition to the viral structural
proteins. Importantly, however, double-labelled particles
retained significant infectivity and this approach therefore
appeared suitable for SVT.
Preparation of double-labelled replication-defective HIV-1
variants for live cell imaging
For live-cell imaging experiments, it is desirable to use
replication-defective HIV-1 derivatives that can be investigated
in biosafety level 1 laboratories. We had previously used an
HIV-1 expression plasmid (pKHIV), which produces all viral
proteins except Nef and is fully entry-competent, but does not
support a complete replication cycle, due to lack of the viral
LTR sequences (Müller et al., 2004). Attempts to purify double-
labelled particles from cells co-transfected with pKHIV
derivatives and pmRFP.Vpr were not successful, however.
Even low amounts of the mRFP.Vpr plasmid strongly reduced
expression from pKHIV, resulting in extremely low particle
release. This problem could be overcome by transferring the
complete HIV-1-derived coding sequence into the mammalianFig. 3. Variation of labelling intensities. (A) Increasing the relative amount of Vpr. V
with increasing amounts of pmRFP.Vpr relative to HIV-derived plasmids. Numbers
constant amount of an equimolar mixture between pCHIVand pCHIVeGFP (set to 1.0
by SDS–PAGE and analyzed by immunoblotting using the indicated antisera. Parti
relative amount of Gag.eGFP. Cells were co-transfected with the indicated ratios
derivatives and the relative amount of pmRFP.Vpr was kept constant (1.0 pCHIV deri
A. Positions of molecular weight standards (in kDa) are indicated to the left.expression vector pcDNA3.1 capable of episomal replication in
293T cells. The resulting plasmids pCHIV and pCHIV.eGFP
allowed efficient co-expression together with mRFP.Vpr.
Double-labelled particles were generated by co-transfection
of pCHIV derivatives and pmRFP.Vpr into 293T cells,
harvested from the tissue culture supernatant and concentrated
by centrifugation through a sucrose cushion. Immunoblot and
fluorescence microscopy analysis of such particles yielded
similar results as obtained for the infectious virus preparations.
Since the presence of mRFP.Vpr had appeared to affect Gag
processing (Fig. 1A), the optimal amount of mRFP.Vpr was
defined by titration experiments. As shown in Fig. 3A, the
relative amount of exogenously expressed mRFP.Vpr incor-
porated into particles correlated with the amount of expression
plasmid transfected. Whereas a maximum amount of mRFP.
Vpr per particle is desirable for optimal detection in real-time
imaging, increased mRFP.Vpr incorporation resulted in
decreased Gag processing efficiency and compromised HIV
protein expression and particle release (Fig. 3A). If Vpr
incorporation would be limited by molecular crowding, this
may be overcome by decreasing the relative amount of Gag.
eGFP per particle. Fig. 3B shows, however, that changing the
ratio of wt Gag to Gag.eGFP from 1:1 to 1:4, while keeping
the total ratio of Gag to Vpr constant, did not lead to increased
mRFP.Vpr incorporation and did not alter Gag processing
(Fig. 3B). Based on these results and microscopic evaluation
of the respective particle preparations (not shown), a molar ratio
of 1:1:0.4 (pCHIV:pCHIVeGFP:pmRFP.Vpr) was determinedLPs were prepared from the tissue culture supernatant of 293T cells transfected
above the lanes indicate the relative amount of pmRFP.Vpr co-transfected to a
). Equivalent amounts of particles, as determined by p24 ELISA, were separated
cle yield was determined by ELISA quantitation of p24 CA. (B) Changing the
of wild-type versus eGFP-labelled pCHIV, while the total amount of pCHIV-
vatives: 0.2 pmRFP.Vpr). Particles were analyzed by immunoblotting as in panel
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mature particle production and was therefore used in all sub-
sequent experiments.
Characterization of double-labelling efficiency
Discrimination between complete particles and subviral
complexes based on the colour of the signal depends on a high
degree of double-labelling. To quantitate the labelling
efficiency, concentrated particles were adhered to glass cover-
slips and visualized at the conditions subsequently used for
single virus tracing (Fig. 4A). Integrated fluorescence inten-
sities of individual signals were quantitated using an automated
data analysis routine. Fig. 4B displays eGFP and mRFP signal
intensities from a representative preparation, each data point
corresponding to an individual particle (n=516). The eGFP
and mRFP intensity distributions for labelled particles are
fairly broad. This variability is expected since HIV-1 particles
display a flexible architecture with a broad range of diameters
and are composed of variable amounts of Gag polyproteins
(Wilk et al., 2001; Briggs et al., 2003, 2004). Most likely, it is
this structural flexibility that allows the insertion of the
relatively large eGFP domain into Gag without disrupting
particle formation. A contribution of slightly uneven ratios of
MA.eGFP:MA in different particles to the varying signal
intensity cannot be excluded; however, a particle preparation
lacking the unlabelled MA variant displayed an even broader
distribution in eGFP intensities (data not shown). Variation in
mRFP intensities was also expected because the number of VprFig. 4. Quantitation of double-labelling efficiency. (A) Particles were adhered to glas
live cell imaging. (B) The integrated eGFP and mRFP1 fluorescence intensities of
Materials and methods and plotted in arbitrary fluorescence units (values on the x and
Lines indicate the threshold as specified in Materials and methods. Particles displayi
were counted as double labelled.molecules incorporated per particle is variable, depending on
e.g. the expression efficiency in the host cell. Fig. 4B shows a
rough correlation between the red and green fluorescence
intensities of individual particles. This indicates that particles
containing more MA.eGFP – presumably larger particles –
also contained more mRFP.Vpr.
Given the wide variability in the eGFP and mRFP intensities,
distinguishing single-labelled from double-labelled particles
becomes a question of detection efficiency. For purpose of
quantification, a value of one standard deviation above the
background intensity was chosen as the minimum detection
level. These levels are shown as lines in Fig. 4B. Particles to the
left of the vertical line are considered red only and particles
below the horizontal line are considered green only. Using these
criteria, 92% of the particles were determined to be double-
labelled, whereas 6.2% displayed only a green signal (MA) and
1.4% were found positive for the red signal (Vpr) only. The
number of single-coloured particles determined using the
method above represents an upper estimate as single-coloured
signals corresponding to protein aggregates from broken
particles would also be included in the evaluation. This could
be confirmed using a preparation lacking wild-type Gag, which
also displayed ∼1% of mRFP.Vpr-only signals (data not
shown). Since only labelled Gag was present, the red-only
signal could not correspond to complete single-labelled
particles. Microscopic analysis of a mock particle preparation
from cells expressing only mRFP.Vpr on the other hand did not
reveal any fluorescent signals indicating that mRFP.Vpr is not
released from cells in the absence of particle production (datas coverslips and visualized. Microscope settings were identical to those used for
single particles adhered to a glass coverslip were determined as described in
y axis correspond to integrated pixel intensities determined, divided by 100,000).
ng signal intensities above the threshold in both channels (upper right quadrant)
Fig. 5. Entry competence of fluorescently labelled particles. VLPs carrying the
Vpr.BlaM reporter protein were prepared from 293T cells co-transfected with
pCHIVand pMM310 expression plasmid (open symbols) or pCHIV, pCHIV.eGFP
and pMM310 (filled symbols), respectively. Particles pelleted from the supernatant
were quantitated by p24 ELISA, titrated in triplicate on HeLaP4 cells and fusion
efficiency was analyzed as described in Materials and methods. Mean values of
triplicates are plotted. Squares and diamonds represent values from two
experiments using independent VLP preparations.
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preparations revealed some variation in relative double-
labelling efficiencies between preparations, an analysis of
double-labelling efficiency needs to be performed as a routine
quality control for each particle preparation to be used in live
cell imaging experiments.
Entry competence of fluorescently labelled particles
To determine the suitability of the fluorescently labelled,
replication-defective particles for live cell imaging, we analyzed
their fusion efficiency using a quantitative entry assay. This
assay makes use of the incorporation of a Vpr-β-lactamase
fusion protein (Vpr.BlaM) into particles. Enzymatically active
BlaM is released into the cytoplasm upon fusion and can be
quantitated by determining cleavage of the fluorescent substrate
CCF2 (Cavrois et al., 2002; Münk et al., 2002). Although the
Vpr.BlaM fusion protein is clearly not identical to the mRFP.
Vpr fusion protein, we used this assay as a model system to
compare the entry efficiency of MA.eGFP-labelled particles
carrying an exogenously expressed Vpr fusion protein with their
wild-type MA counterparts. Particles were titrated in parallel onFig. 6. Different types of virus–cell interactions observed in live cell imaging experi
images were recorded at a time resolution of 100 ms per overlay image as described in
superimposed on a bright light image of cells. Free diffusion of double-labelled particl
particles at the cell membrane (trace type c), as well as intracellular movement of do
4 μm. Corresponding movies are provided as supplementary material.HeLaP4 cells and fusion efficiency was quantitated by
determining CCF2 cleavage. The result was similar for particles
containing or lacking Gag.eGFP over a wide concentration
range, indicating that the presence of MA.eGFP did not
significantly affect the fusogenicity of particles (Fig. 5). We
conclude that the presence of the MA.eGFP in VLPs does not
significantly alter their fusion competence and MA.eGFP-
labelled particles are suited for the real-time imaging of entry
kinetics.
Tracing of individual fluorescent particles in real time
To determine the suitability of the double-fluorescent
particles for live cell imaging of HIV-1 host cell interactions,
we performed exemplary experiments on HeLaP4 cells.
Double-labelled particles were added at a concentration similar
to that used in the infection assays (25–100 ng p24/104 cells)
and followed with a time resolution of 50 ms per frame. This
gives a total time resolution per double-colour exposure of
100 ms since the excitation wavelength was alternated with
each frame. Using the microscope setup described in Materials
and methods, double-labelled particles were easily detected and
traced under these conditions. Four different classes of events
were observed and are summarized in Fig. 6 (movies displaying
the indicated traces are provided as supplementary material). (i)
Double-labelled, complete particles were detected in free
diffusion between cells (Fig. 6, trace type a); (ii) complete,
extracellular particles briefly touched the cell surface for a
duration of 1–2 frames (<200 ms), before resuming free
diffusion (Fig. 6, trace type b); (iii) double-labelled particles
became immobile at the membrane immediately after cell
contact (Fig. 6, trace type c); and (iv) double-labelled as well as
some single-labelled particles displayed intracellular movement
(Fig. 6, trace type d). Immobilization of double-labelled
particles at the plasma membrane (trace type c) was a frequent
event with most of these particles remaining immobile and
double-coloured during the observation period. The majority of
immobilized particles stayed double-labelled, even when the
observation period was extended at lower temporal resolution to
over 2 h at 37 °C, indicating that membrane fusion did not occur
(data not shown). Accordingly, such particles accumulated atments. HeLaP4 cells were incubated with double-labelled particles at 37 °C and
Materials and methods. Exemplary traces of double-labelled particles are shown
es (trace type a), brief touches of the cell surface (trace type b), immobilization of
uble-labelled (trace type d) or single-labelled particles were observed. Scale bar:
98 M. Lampe et al. / Virology 360 (2007) 92–104the plasma membrane over time. These results indicate that
immobilization of complete particles represents largely unpro-
ductive virus attachment (see also below).
The majority of fluorescent signals displaying intracellular
movement were dual-coloured (Fig. 6, trace type d and
supplementary material), indicating uptake of complete parti-
cles. This is in accordance with the fact that endocytosis of HIV
particles can be readily observed in various cell types.
Intracellular particles were most readily observed at time points
greater than 10 min after fluorescent particle addition. Some
complete particles displaying intracellular movement could
already be detected at the earliest possible observation times
after particle addition (∼1 min), indicating very rapid endo-
cytotic events. Besides double-labelled particles, we also
observed some single-labelled signals undergoing directed
movement within the cell, while no actual colour separation
event was seen among >7000 particle traces observed. This was
also the case when the HeLa derivative JC53, which had been
selected for a particularly high surface expression of CD4 (Platt
et al., 1998), was used in similar experiments (data not shown).
The detection of intracellular particles carrying only the mRFP.
Vpr label suggested that membrane fusion had occurred. This
conclusion is not unequivocal, however, since the fluorescent
particle preparations contained a low percentage of single-
coloured signals (Fig. 4), which cannot be distinguished from
subviral particles after fusion. It should be emphasized that this
also holds true for previous studies tracing fluorescent Vpr
complexes (McDonald et al., 2002). This limitation can only be
overcome if the descent of an individual single-coloured signal
from a double-labelled particle can be ascertained by observing
the actual entry event (as colour separation) within the window
of observation.
Observation of bulk colour separation
In the absence of observation of individual fusion events in
the experiments described above, we aimed to verify that fusion
would lead to a separation of colours. For this, we generated
double fluorescently labelled pseudotyped particles, in which
the HIV-1 envelope protein was replaced by the glycoprotein G
from vesicular stomatitis virus (VSV-G), which mediates highly
efficient entry into HeLaP4 cells. Unlike HIV-1 entry, VSV-G
mediated uptake occurs through endocytosis followed by pH-
triggered fusion with the endosomal membrane and can be
blocked by bafilomycin A (Matlin et al., 1982; Palokangas
et al., 1994). As expected, incubation of HeLaP4 cells with
pseudotyped particles resulted in rapid intracellular accumula-
tion of double-labelled particles. Upon prolonged incubation,
we observed the appearance of a diffuse MA.eGFP signal in the
cytoplasm, while an increased mRFP.Vpr signal was detected in
the nuclear region (Fig. 7, upper two panels). Use of
pseudotyped particles labelled with MA.cherry/eGFP.Vpr in
an identical experiment resulted in the opposite colour
distribution, indicating that the relative distribution of the
fluorescent proteins was determined by the viral fusion partners
(data not shown). The diffuse cytoplasmic distribution we
observed for the MA signal, which is in stark contrast to thepronounced membrane staining of target cells resulting from
fusion of murine leukemia virus carrying a YFP-labelled
envelope protein (Sherer et al., 2003), indicated that MA did
not remain stably attached to the endosomal membrane after
fusion had occurred. When bafilomycin A was added to block
pH-mediated fusion, no separation of the red and green signals,
but rather very similar distribution of intensities in both
channels was detected (Fig. 7, lower two panels). In this case,
very large double-coloured structures were found close to the
nucleus, presumably representing particles trapped in endo-
lysosomal structures. Accumulation of spatially separated bulk
fluorescent signals was also not observed for particles lacking
any viral surface protein and therefore incompetent for entry
(data not shown). These data clearly indicate that a fusion-
dependent separation of red and green signals does occur in our
system. However, even when using efficiently fusing VSV-G
pseudotyped particles, we did not visualize individual colour
separation events. This may partly be explained by the strong
double-coloured signals resulting from particles accumulated in
endosomes, which would render detection of the weaker signal
of individual fusion events difficult (see also below).
Role of heparan sulfate in particle immobilization and uptake
In the studies with HIV-1 envelope carrying particles
described above, it became apparent that the large number of
immobile complete particles accumulating at the cell surface
presents a major obstacle for microscopic detection of single
fusion events. Immobilization of complete particles was also
observed, albeit at a lower frequency, when particles lacking the
viral envelope protein were used (Fig. 8B and data not shown).
This result indicated that an attachment factor different from the
specific gp120–CD4 interaction contributed to this stable cell
surface binding. Work from several laboratories has established
that heparan sulfate – although not essential for HIV-1 entry –
can play a role in the attachment of HIV-1 (Ugolini et al., 1999).
This interaction has been reported to be of functional
importance at least in some host cells (Bobardt et al., 2003;
Zhang et al., 2002). Based on these results, we tested if heparan
sulfate was responsible for the apparently non productive
immobilization of double-labelled particles to HeLaP4 cells.
Cells were treated for 30 min with heparinase I to remove
heparan sulfate from the cell surface and the efficacy of
treatment was confirmed by flow cytometry using an anti-
heparan sulfate antibody (data not shown). Since previously
published studies investigated the effect of heparinase treatment
on virus attachment by binding at low temperature, we first
incubated heparinase-treated as well as mock-treated cells with
fluorescent particles for 30 min on ice. Subsequently, the
amount of bound fluorescence was quantitated by flow
cytometry. Fig. 8A shows that fluorescent particle binding to
cells was reduced to undetectable levels in heparinase-treated
cells, indicating that heparan sulfate serves as major attachment
factor on these cells.
Next we analyzed the effect of heparinase treatment on
fluorescent particle immobilization under live cell imaging
conditions (Fig. 8B). As observed in the previous experiments,
Fig. 7. Intracellular separation of MA and Vpr attached signals upon entry of VSV-G pseudotyped VLPs. HeLaP4 cells were pre-incubated for 25 min in the presence
or absence of 25 nM bafilomycin A as indicated. Subsequently MA.eGFP/mRFP.Vpr-labelled VLPs pseudotyped with VSV-G protein were added and incubation was
continued at 37 °C. Images shown here were recorded approximately 2 h after addition of virus as described under Materials and methods. Two images from the same
experiment are shown for each condition.
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at 37 °C led to the accumulation of large numbers of immobilized
dual-labelled particles at the cell surface. Concordant with the
data obtained by flow cytometry (Fig. 8A), enzymatic removal
of heparan sulfate from the cell surface strongly reduced the
accumulation of immobile particles under live cell imaging
conditions at 37 °C, while brief membrane contacts were still
observed. Stable attachment of complete VLPs to heparinase-
treated cells was slowly recovered upon prolonged incubation
(>1 h after removal of heparinase), presumably due to newly
synthesized heparan sulfate linked proteoglycans (data not
shown). These results indicate that heparan sulfate can capture
complete HIV-1 particles at the cell surface in an apparently
non-productive way. Heparan sulfate also contributed to
fluorescent particle endocytosis (Fig. 8C). While large amountsof double-labelled particles accumulated within untreated cells
upon prolonged incubation (>20 min), only a few intracellular
particles were detected in treated cells under the same
conditions. It is currently not clear, however, whether this
indicates that endocytosis is a consequence of prior membrane
immobilization. While this is suggested by their common
dependence on cell surface heparan sulfate, there are at least
some particles that remain immobilized at the cell surface for
several hours and may never be endocytosed.
To investigate whether abolishing particle immobilization
affected productive HIV-1 infection, we determined the effect of
heparinase treatment on infection. Previous studies of this kind
have yielded different results, depending on the virus isolate, the
source of virus, the host cell and the assay conditions used
(Zhang et al., 2002 and references therein). For HeLa CD4 cells,
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HIV infection (Mondor et al., 1998) or to have no effect on HIV
susceptibility (Ibrahim et al., 1999), respectively. To test for the
effect of our treatment on productive infection, the HeLa-derived
TZM reporter cell line (Wei et al., 2002) was incubated with
heparinase as above and infected with wild-type HIV-1NL4-3.
Virus entry was blocked by treatment with the entry inhibitorAMD3100 after 30 min or 5.5 h, respectively, and infection was
quantitated by measuring luciferase activity in cell extracts at
48 h after virus addition. Parallel infection experiments were
carried out in DMEM or in PBS supplemented with Mg2+ and
Ca2+, respectively, because the latter had been used in imaging
experiments. As shown in Fig. 8D, productive infection was
reduced approximately 2.5-fold, but clearly not abolished by
101M. Lampe et al. / Virology 360 (2007) 92–104heparinase treatment. While the overall infection rate was lower
when virus fusion was blocked after 30 min, the relative effect of
treatment was very similar for both entry times tested.
Replacement of DMEM by supplemented PBS during infection
had no effect.
These experiments revealed that heparinase treatment only
moderately decreased HIV-1 infection, while almost comple-
tely abolishing immobilization of complete particles at the
plasma membrane. This result supports the hypothesis that the
majority of immobilized particles represent products of non-
productive interaction. We speculate that the heparinase-
mediated reduction in infectivity can be explained, at least in
part, by the decreased endosomal uptake following heparinase
treatment (compare Fig. 8C). We had previously shown that
inhibition of clathrin-dependent endocytosis decreased pro-
ductive HIV infection in a HeLaP4-derived cell line by 40–
90% (Daecke et al., 2005). In summary, removal of heparan
sulfate from the cell surface provides improved conditions for
live cell imaging of entry kinetics since accumulation of
double-labelled particles at the cell surface is virtually
abolished and endocytosis of complete particles is strongly
reduced, while virus entry by fusion at the plasma membrane
can still occur.
In this report, we have generated and characterized that dual
fluorescent HIV-1 derivatives, which display a high degree of
double labelling, are fully entry competent and are well suited to
study cell interaction of single particles with high time
resolution. Optimal conditions for the observation of single
virus–cell interactions at the plasma membrane with high time
resolution were established and removal of cell surface heparan
sulfate was found to be important to avoid obscuring fusion
events by immobilized complete particles. As outlined above,
we expect that membrane fusion should be indicated by the
spatial separation of the eGFP and mRFP signals from one
particle.Whereas we could follow a large number of the different
types of virus–cell interactions summarized in Fig. 6, clear
colour separation events at the plasma membrane were not
apparent in several hundred particle traces analyzed in the initial
imaging experiments, suggesting that HIV fusion at the plasma
membrane occurs only rarely in comparison to the brief
membrane touches, particle immobilization and endocytosed
particles observed. When fusion efficiency was enhanced by the
use of VSV-G pseudotyped VLPs, increasing bulk separation of
colours over time clearly indicated that fusion, followed by
separation of MA and CA did occur. The reason why noFig. 8. Effects of heparinase treatment on VLP immobilization and cell infectabilit
heparinase treatment, HeLaP4 cells were incubated with fluorescently labelled VLPs
by flow cytometry as described in Materials and methods. Blue line: autofluorescenc
Effect on VLP immobilization as visualized in live cell imaging experiments. Hepar
HIV-1 Env proteins or an Env(−) variant, respectively, at 37 °C and monitored und
Images shown here were recorded 45 min after addition of particles. Fifty consecuti
diffusing particles in solution. (C) Reduction of particle endocytosis after removal of h
were recorded 20 min and 40 min post-addition of Env(+) VLPs, respectively, as des
images is marked (*). Scale bar: 10 μm. The corresponding movies are provided as
treatment for 30 min, treated (grey bars) or mock-treated (black bars) HeLa TZM
indicated times and infection was scored by measuring the activity of the Tat-d
Measurements were carried out in triplicate. One representative out of three indepenindividual fusion events were observed in this case is presently
unclear. It is possible that the frequency of events was still too
low to capture events in single cells during the necessarily short
observation periods of the real-time measurements. Addition-
ally, whileMcDonald et al. (2002) have shown that fluorescently
labelled Vpr can be used to microscopically follow subviral
complexes within the cell, we cannot exclude that a proportion
of the incorporated mRFP.Vpr protein does not stay attached
with the viral core, which would result in a concomitant decrease
of signal intensity in both channels upon fusion. Furthermore,
although it is generally believed that the majority of virion-
associated MA molecules is not part of the subviral complex
trafficking to the nucleus, it cannot be ruled out at present that the
separation of the MA layer from the viral core is incomplete at
the time of fusion. While our data clearly indicate that MA does
not stay attached to the membrane after fusion, definition of the
precise stages of entry will likely only be possible using
automated quantitative analyses of movements and changes in
relative colour distribution over time of individual particles from
a large number of movies. Combining the entry competent
double-labelled virions described here with automated tracking
of many individual events should thus provide us with a
powerful tool for investigating the entry pathway of HIV.
Materials and methods
Plasmids
The infectious HIV-1 proviral plasmid pNLC4-3 and its
fluorescently labelled derivative have been described previously
(Bohne and Kräusslich, 2004; Müller et al., 2004). Plasmids
pCHIVand pCHIV.eGFP were constructed by cloning an XhoI–
XbaI fragment comprising the complete HIV-derived sequence
from pKHIV and pKHIV.eGFP (Müller et al., 2004), respec-
tively, into pcDNA3.1(Zeo)-(Stratagene). Plasmids pCHIV
(Env-) and pCHIV(Env-) were constructed from their wt env
counterparts by exchange of an AgeI–XhoI fragment with the
corresponding fragment from subviral plasmid PA3, in which
the NdeI site at nt 6401 of the NL4-3 proviral sequence was
filled in with Klenow polymerase to generate a frameshift in the
env gene. Plasmid pmRFP.Vpr was constructed from peGFP-
Vpr (McDonald et al., 2002) by excising the eGFP open reading
frame using NheI and ScaI and replacing it with a NheI–ScaI
PCR fragment encoding the mRFP1 open reading frame
amplified from plasmid pRSET-mRFP1 (Campbell et al., 2002).y. (A) Effect on VLP attachment as determined by flow cytometry. Following
for 30 min on ice and the particle-associated eGFP fluorescence was determined
e of cells; green line: mock-treated cells; black line: heparinase-treated cells. (B)
inase-treated or mock-treated HeLaP4 cells were incubated with VLPs carrying
er conditions used for live cell imaging as described in Materials and methods.
ve frames each (5 s in total) were averaged to dispose of signals resulting from
eparan sulfate by heparinase from the surface of HeLaP4 cells. Data shown here
cribed for Fig. 8B. Cellular autofluorescence in the nuclear region in one of the
supplementary material. (D) Effect on cell infectability. Following heparinase
cells were incubated with HIV-1NL4-3 corresponding to 50 ng p24/well for the
ependent luciferase reporter protein as described in Materials and methods.
dent experiments is shown.
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Polyclonal rabbit antisera were raised against purified
recombinant MA protein or a synthetic full-length Vpr peptide,
respectively. Rabbit antiserum raised against gp120 was kindly
provided by V. Bosch (DKFZ, Heidelberg).
Tissue culture
293T cells, HeLaP4 cells and TZM reporter cells (Wei et al.,
2002) were kept in Dulbecco's modified Eagle's medium
(DMEM), supplemented with 10% fetal calf serum, penicillin,
streptomycin and glutamine. Cells destined to be used in live
cell imaging were cultivated in HybridoMed 1000F medium
(Biochrom). Imaging was performed in PBS supplemented with
1 mM CaCl2 and 0.5 mM MgCl2.
Preparation of labelled particles
293T cells were transfected with a mixture of unlabelled and
eGFP-labelled HIV-1-derived plasmids (pNLC4-3, pCHIV and
derivatives) and pmRFP.Vpr at the indicated molar ratio by
calcium phosphate precipitation. For generation of VSV-G
pseudotyped particles, cells were transfected with a plasmid
expressing VSV-G protein (Emi et al., 1991) together with
pCHIV(Env-), pCHIV.eGFP(Env-) and pmRFP.Vpr. At 44 h
post-transfection (hpt), medium was harvested and cleared by
filtration through a 0.45-μm filter. Particles were concentrated
by ultracentrifugation through a 20% (w/w) sucrose cushion.
Particles were resuspended at 3.3 μl/ml culture supernatant in
ice-cold phosphate-buffered saline (PBS) supplemented with
10% fetal calf serum and 10 mM HEPES pH 7.3, rapidly frozen
in liquid nitrogen and stored at −80 °C. The particle
concentration was quantified by p24 ELISA. To determine the
relative fluorescence intensity of particle preparations, emission
spectra were recorded at excitation wavelengths of 488 nm
(eGFP) or 584 nm (mRFP), respectively, using an SLM Aminco
spectrofluorometer.
Infection of TZM reporter cells
The infectivity assays were performed in a 96-well plate
format. 5×103 TZM cells per well were plated and infections
were carried out on the following day adding cleared and filtered
medium from 293T producer cells, transfected with the indicated
plasmids. After 48 h, cells were lysed and HIV Tat driven
luciferase activity was measured using the Steady-Glo-Assay
(Promega) according to the manufacturer's recommendations.
For evaluation of the effect of heparinase treatment, cells
were seeded as before. After 24 h, the medium was removed and
100 μl PBS containing 2 U of heparinase I (Sigma) were added.
Following 30min of incubation at 37 °C, the heparinase solution
was removed. Sucrose pelleted NL4.3 virus (amount equivalent
to 50 ng CA determined by p24 ELISA) was diluted in PBS
supplemented with 1 mMCaCl2 and 0.5 mMMgCl2,or DMEM/
10%FCS and the cells were incubated with the virus dilution for
the indicated times at 37 °C. Subsequently, virus was removedand DMEM containing 10 ng/ml AMD3100 (obtained through
the NIH AIDS Research and Reference Reagent Program) was
added to prevent further infection. At 18 h post-infection, 10 μM
AZT (Sigma) was added to prevent second round infections. On
the following day, medium was removed and luciferase reporter
gene activity was quantified as above.
Beta-lactamase fusion assay
Particles carrying a Vpr-β-lactamase (Vpr.BlaM) fusion
protein were obtained by co-transfection of 293T cells with
pCHIV or an equimolar mixture of pCHIV and pCHIV.eGFP,
respectively, and plasmid pMM310 (Münk et al., 2002)
encoding the Vpr.BlaM fusion protein (5 μg pMM310: 15 μg
pCHIV). Particles were harvested from the tissue culture
supernatant at 44 hpt, concentrated by centrifugation through
a sucrose cushion and their concentration was determined by
p24 ELISA after heating for 10 min in 1% SDS. HeLaP4 cells
(4×104 cells/well) were incubated in a 96-well plate (Costar
#3603) with serial dilutions in 100 μl DMEM/10% FCS for
3.5 h at 37 °C. Subsequently, virus was removed, cells were
washed once with CO2-independent medium (Invitrogen), 70 μl
of CCF2 β-lactamase loading solution (Invitrogen; prepared
according to the manufacturer's instructions) was added and
incubation was continued for 12 h at room temperature. Cells
were washed with PBS, fixed with 3% paraformaldehyde and
relative fluorescence intensities (excitation wavelength 409 nm,
emission wavelengths 447 nm and 512 nm) were recorded using
a TECAN Safire instrument. After subtraction of background
from unstained cells at the respective emission wavelength, the
ratio of emission intensities at 447/512 nm was calculated. The
ratio obtained from mock-infected CCF2 stained cells was
subtracted as background from all values obtained in the
presence of virus.
Flow cytometry
Virus binding assays were performed using fluorescently
labelled particles (60 ng p24 per 106 cells). Cells were harvested in
PBS containing 0.7 mM EDTA, incubated with labelled particles
for 30min on ice, washed and subjected to flow cytometry using a
FACSCalibur instrument and CellQuestPro software (Becton
Dickinson). Bound virus was quantified by determining eGFP
mean fluorescence. For heparinase treatment, cells were incubated
with 2U of heparinase I (Sigma) in 100μl PBS for 30min at 37 °C
and washed twice with ice-cold PBS before virus addition. The
efficiency of heparinase treatment was controlled by flow
cytometry using a murine FITC-labelledmonoclonal anti-heparan
sulfate antibody (Clone 10E4, Seikagaku). After heparinase or
mock treatment, the cells were washed and incubated with 100 μl
of a 1:20 dilution of the antibody in PBS for 30 min on ice,
subsequently washed and analyzed.
Live cell microscopy
For live cell fluorescence microscopy, cells were seeded at a
density of 1×104 cells per well on chambered cover glass (Lab-
103M. Lampe et al. / Virology 360 (2007) 92–104Tek, Nunc, #155411), precoated with collagen (Biochrom).
After overnight incubation at 37 °C, medium was removed and
fluorescently labelled virus, diluted in PBS supplemented with
0.5 mM MgCl2 and 1 mM CaCl2 was added. For imaging, we
used a highly sensitive wide field setup (Visitron Systems) based
on a Zeiss Axiovert 200 M microscope equipped with a back
illuminated EM-CCDCamera (Cascade II, Roper Scientific) and
an xyz-motorized stage (Applied Scientific Instrumentation). All
experiments were performed at 37 °C using a microscope
incubator chamber (EMBLEM, Heidelberg, Germany). Bright
light images of cells were collected before theywere observed by
fluorescence microscopy. For excitation of the fluorophores, a
Lambda DG4 light source (Sutter Instrument) was used, which
allowed fast alternating excitation with appropriate single band
filters for eGFP and mRFP1 (Chroma), respectively. The dual
band eGFP/mRFP emission filter (Chroma) displayed no
crosstalk under the imaging conditions used. Image acquisition
and microscope control were performed with Metamorph
(Universal imaging, Visitron). Images were recorded using the
16-bit range of the EMCCD camera with maximum amplifica-
tion of the fluorescence signal, resulting in 65,536 grey values or
relative intensity units (IU). In a typical data set, the offset in the
GFP/RFP-channel was 5000/4200 IU and the mean intensity of
noise was 9000/7100 IU with a standard deviation of 1500/
1000 IU. VLP-derived signals were clustering between 11,000/
9000 and 15,000/11,500 IU, with maximal signal intensities
reaching 42,000/26,000 IU. VLPs were tracked by hand using
the manual tracking feature of Metamorph.
For the experiments with VSV-G pseudotyped VLPs, cells
seeded on the previous day were pre-incubated for 25 min in
PBS supplemented with 0.5 mM MgCl2/1 mM CaCl2 in the
presence or absence of bafilomycin A1 (Calbiochem; final
concentration 25 nM) at 37 °C. Subsequently, virus was added
and incubation was continued for 2 h at 37 °C. Data were
recorded using a custom built microscope (Endress et al.,
manuscript in preparation) under comparable imaging condi-
tions than those used in the other experiments. A pair of images
was collected every 100 ms, one in each colour channel,
focussing through a section in the middle of the cell. Frames
number 6–10 from the respective channel were averaged and
colour merged with identical display levels for all images and
both colours, to generate the images shown in Fig. 7.
Determination of double labelling efficiency
Fluorescent particles were diluted in PBS and adhered to a
glass coverslip. After focussing on the particles, the field of view
was shifted to a neighboring area to record unbleached particles.
To compensate for small focus differences, a z-stack with 0.1 μm
spacing was recorded for both colours and the sharpest image of
each colour was selected. Images were analyzed using ImageJ
(http://rsv.info.nih.gov/ij/). Individual particles were identified
visually in either the red or green channel, and the centres of the
particles were marked. The intensity of the signal in each
channel was defined as the integrated density within a circle of
five pixel radius centered at the marked point. A minimum of
500 particles per preparation was measured. Background wascalculated as the mean of a minimum of 100 equivalent
measurements taken at positions where no particle was visible. A
particle was considered as single labelled if the intensity in one
channel was below one standard deviation of the mean
background fluorescence from that channel.
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